Learn more

SELECTIVE GENETICS INC

Overview
  • Total Patents
    52
About

SELECTIVE GENETICS INC has a total of 52 patent applications. Its first patent ever was published in 1996. It filed its patents most often in United States, Australia and EPO (European Patent Office). Its main competitors in its focus markets biotechnology, pharmaceuticals and organic fine chemistry are PAEAN BIOTECHNOLOGY INC, TESSA THERAPEUTICS PTE LTD and DEISSEROTH ALBERT B.

Patent filings per year

Chart showing SELECTIVE GENETICS INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Baird Andrew 30
#2 Larocca David 26
#3 Kassner Paul 12
#4 Sosnowski Barbara A 9
#5 Chen Xian 9
#6 Johnson Wendy 8
#7 D Andrea Mark J 7
#8 Pierce Glenn 5
#9 Berry Martin 5
#10 Logan Ann 5

Latest patents

Publication Filing date Title
AU2003222171A8 Compositions and methods for portal specific gene delivery and treatment of infection
WO03029429A2 Traversal of nucleic acid molecules through a fluid space and expression in repair cells
US2003148263A1 Methods and compositions using genetic package display
AU9140801A Adenoviral vectors with modified tropism
US6723512B2 Methods using genetic package display for detecting and identifying protein-protein interactions that facilitate internalization and transgene expression and cells or tissues competent for the same and methods for evolving gene delivery vectors
AU1939801A In situ bioreactors and methods of use thereof
US6451527B1 Methods using genetic package display for selecting internalizing ligands for gene delivery
WO9940771A2 Concurrent flow mixing for preparing compositions comprising gene therapy vectors
US6589730B1 Methods for identifying protein-protein interactions by selective transduction
US6251599B1 Stabilized nucleic acid compositions and methods of preparation and use thereof
WO9910485A1 Methods using phage display for selecting internalizing ligands for gene delivery
AU6462998A Adenoviral vectors with modified tropism
US6054312A Receptor-mediated gene delivery using bacteriophage vectors
EP0923387A2 Heparin-coated medical devices for intravenous use containing heparin-binding growth factor conjugates
US6037329A Compositions containing nucleic acids and ligands for therapeutic treatment